Skip to main content
TipRanks
Go Ultimate75% OFF

Sangamo Therapeutics (SGMOQ) Q2 2022 Earnings Report

2,675 Followers

SGMOQ Q2 2022 EPS Results

Actual EPS
-$0.29
Consensus EPS
-$0.35
Beat/Miss
Beat by +$0.06
One Year Ago EPS
-$0.33

SGMOQ Q2 2022 Revenue Results

Actual Revenue
$29.38M
Expected Revenue
$24.63M
Beat/Miss
Beat by +$4.75M
YoY Revenue Growth
+5.40%

Earnings Announcement Details

Quarter
Q2 2022
Date
08/04/2022
Time
After Close
Conference Call
Thursday, August 4, 2022
SGMOQ Upcoming Earnings

Sangamo Therapeutics's next earnings date is estimated for February 24, 2027, based on past reporting schedules.

Q2 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

SGMOQ Earnings History

SGMOQ earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 24, 20272026 (Q4)―--0.11――
Oct 29, 20262026 (Q3)―--0.11―
Aug 11, 20262026 (Q2)-0.07--0.08―
May 14, 20262026 (Q1)0.01-0.08-0.1442.86% (+0.06)
Mar 30, 20262025 (Q4)0.01-0.11-0.110.00% (+0.00)
Nov 06, 20252025 (Q3)0.00-0.110.04-375.00% (-0.15)
Aug 07, 20252025 (Q2)-0.01-0.08-0.1855.56% (+0.10)
May 12, 20252025 (Q1)-0.12-0.14-0.2748.15% (+0.13)
Mar 17, 20252024 (Q4)-0.09-0.11-0.3467.65% (+0.23)
Nov 12, 20242024 (Q3)-0.010.04-0.59106.78% (+0.63)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed